Drug Trial Radar · NCT00492037
Study of Efficacy & Safety of Oral YM087 in Subjects With Euvolemic or Hypervolemic Hyponatremia
Last checked: Nov 19, 2026Latest source record: May 2, 2014 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
83
Actual
Start
Jan 2000
Primary completion
Not stated
Study completion Feb 2002
Sponsor
- Lead sponsor
- Cumberland PharmaceuticalsIndustry
- Sponsor type
- Industry
- Collaborators
- Parke-Davis
- First posted
- Jun 27, 2007
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years, up to 85 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Study of efficacy \& safety of oral YM087 in subjects with euvolemic or hypervolemic hyponatremia
Conditions
- Hyponatremia
Interventions
YM087 oralDrug
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change in serum sodium from Baseline Safety of each dosing regimenTime frame: Beginning through end of treatment
Locations
29 sites in 9 countries. Site status is shown where the registry gives one.
Site not named
Brussels, Belgium
Site not named
Liège, Belgium
Site not named
Tournai, Belgium
Site not named
Jyväskylä, Finland
Site not named
Turku, Finland
Site not named
Garches, France
Site not named
Limoges, France
Site not named
Paris, France
Site not named
Bad Nauheim, Germany
Site not named
Berlin, Germany
Site not named
Dresdan, Germany
Site not named
Göttingen, Germany
Site not named
München, Germany
Site not named
Ferrara, Italy
Site not named
Pavia, Italy
Site not named
Pisa, Italy
Site not named
Verona, Italy
Site not named
Delft, Netherlands
Site not named
Groningen, Netherlands
Site not named
Leiden, Netherlands
Site not named
Nijmegen, Netherlands
Site not named
Radomsko, Poland
Site not named
Warsaw, Poland
Site not named
Wroclaw, Poland
Site not named
Barcelona, Spain
Site not named
Córdoba, Spain
Site not named
Madrid, Spain
Site not named
Cardiff, United Kingdom
Site not named
Manchester, United Kingdom
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.